We are live on
!
Find out more
OA
Operose Advisors Portfolio holdings
AUM
$517M
Turnover
40.26%
1-Year Est. Return
24.68%
This Fund
S&P 500
This Quarter
Est. Return
+3.68%
1 Year Est. Return
+24.68%
3 Year Est. Return
+68.8%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$221M
AUM Growth
+$19.3M
(+9.6%)
Cap. Flow
+$12.4M
Cap. Flow
% of AUM
5.62%
Top 10 Holdings %
Top 10 Hldgs %
70.98%
Holding
362
New
18
Increased
66
Reduced
26
Closed
4
Avg Time Held
1.2
years
Top 10 Avg Time Held
1.3
years
Top 20 Avg Time Held
1.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$2.92M |
| 2 |
Vanguard High Dividend Yield ETF
VYM
|
+$1.27M |
| 3 |
iShares International Select Dividend ETF
IDV
|
+$1.05M |
| 4 |
Oracle
ORCL
|
+$929K |
| 5 |
Schwab International Equity ETF
SCHF
|
+$822K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Global Min Vol Factor ETF
ACWV
|
+$468K |
| 2 |
Old National Bancorp
ONB
|
+$294K |
| 3 |
iShares National Muni Bond ETF
MUB
|
+$212K |
| 4 |
iShares US Real Estate ETF
IYR
|
+$177K |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$149K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 84.12% |
| 2 | Financials | 5.12% |
| 3 | Technology | 4.2% |
| 4 | Consumer Discretionary | 2.01% |
| 5 | Healthcare | 1.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
251
Trade Desk
TTD
$5.76B
| $15.4K | 0.01% |
200
| – | – |
2022 Q4
2 quarters
|
|
252
Teva Pharmaceutical Industries Limited
TEVA
$47.5B
| $15.3K | 0.01% |
2,036
| – | – |
2022 Q3
3 quarters
|
|
253
DELISTED
The AZEK Co
AZEK
| $15.1K | 0.01% |
500
| – | – |
2021 Q4
6 quarters
|
|
254
AstraZeneca
AZN
$251B
| $15K | 0.01% |
105
| – | – |
2021 Q4
6 quarters
|
|
255
Schwab U.S Small- Cap ETF
SCHA
$21.3B
| $14.9K | 0.01% |
680
| – | – |
2021 Q4
6 quarters
|
|
256
DELISTED
Interpublic Group of Companies
IPG
| $13.5K | 0.01% |
350
-650
| -65% | -$24.5K |
2023 Q1
1 quarter
|
|
257
BlackLine
BL
$1.7B
| $13.5K | 0.01% |
250
| – | – |
2022 Q1
5 quarters
|
|
258
Simon Property Group
SPG
$64.3B
| $12.7K | 0.01% |
110
| – | – |
2022 Q1
5 quarters
|
|
259
Teladoc Health
TDOC
$1.06B
| $12.7K | 0.01% |
500
| – | – |
2021 Q4
6 quarters
|
|
260
iShares Russell 3000 ETF
IWV
$20.3B
| $12.5K | 0.01% |
49
| – | – |
2022 Q1
5 quarters
|
|
|
FSR
261
DELISTED
Fisker Inc.
FSR
| $12.5K | 0.01% |
+2,210
| New | +$12.7K |
2023 Q2
0 quarters
|
|
262
Dimensional Emerging Core Equity Market ETF
DFAE
$9.75B
| $12.4K | 0.01% |
527
+4
| +0.8% | +$93 |
2021 Q4
6 quarters
|
|
263
Amdocs
DOX
$6.19B
| $12.4K | 0.01% |
125
| – | – |
2022 Q4
2 quarters
|
|
264
VanEck Gold Miners ETF
GDX
$25B
| $12.3K | 0.01% |
410
| – | – |
2022 Q4
2 quarters
|
|
265
Vanguard ESG US Stock ETF
ESGV
$13.5B
| $11.9K | 0.01% |
+152
| New | +$11.2K |
2023 Q2
0 quarters
|
|
266
SSR Mining
SSRM
$6.26B
| $11.9K | 0.01% |
840
| – | – |
2022 Q3
3 quarters
|
|
267
Barrick Mining
B
$64B
| $11.9K | 0.01% |
700
| – | – |
2022 Q3
3 quarters
|
|
268
Kroger
KR
$37.3B
| $11.8K | 0.01% |
+250
| New | +$11.9K |
2023 Q2
0 quarters
|
|
269
Victoria's Secret
VSXY
$7.05B
| $11.6K | 0.01% |
666
| – | – |
2021 Q4
6 quarters
|
|
270
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.6B
| $11.6K | 0.01% |
252
| – | – |
2021 Q4
6 quarters
|
|
271
Workday
WDAY
$45.5B
| $11.3K | 0.01% |
50
-15
| -23% | -$3K |
2023 Q1
1 quarter
|
|
272
CRISPR Therapeutics
CRSP
$4.86B
| $11.2K | 0.01% |
200
| – | – |
2023 Q1
1 quarter
|
|
273
Delta Air Lines
DAL
$50.4B
| $10.9K | ﹤0.01% |
229
| – | – |
2021 Q4
6 quarters
|
|
274
Garmin
GRMN
$53.9B
| $10.8K | ﹤0.01% |
+104
| New | +$10.6K |
2023 Q2
0 quarters
|
|
275
Stryker
SYK
$108B
| $10.7K | ﹤0.01% |
35
| – | – |
2021 Q4
6 quarters
|
|
Similar funds
KPDZUSZIDPFAS
MADR
AWM
CPW
PDIP
BP
DAC
PIN
Operose Advisors's Q2 2023 Portfolio in Review
As of Q2 2023, Operose Advisors held 362 positions worth $221M, up 9.6% from $201M the previous quarter. Its ten largest holdings account for 71% of the portfolio.
Operose Advisors deployed $12.4M of net new capital in Q2 2023, opening 18 new positions and adding to 66 existing holdings. Its largest new stake was TE Connectivity: 5,500 shares worth $771K.
By sector, the portfolio is most concentrated in Miscellaneous at 84% of assets, down from 87% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was iShares MSCI Global Min Vol Factor ETF, an estimated $468K trimmed.
- Operose Advisors's largest Q2 2023 buy was TE Connectivity: 5,500 shares worth $771K.
- Operose Advisors added most to Vanguard Morningstar Total Stock Market ETF in Q2 2023, an estimated $2.92M increase.
- Operose Advisors's biggest Q2 2023 reduction was iShares MSCI Global Min Vol Factor ETF, cutting an estimated $468K.
- Operose Advisors fully exited Clorox in Q2 2023, selling an estimated $19.5K.
- Operose Advisors's ten largest holdings make up 71% of its $221M portfolio in Q2 2023.
- Operose Advisors opened 18 new positions and closed 4 in Q2 2023.
- Operose Advisors's portfolio value rose 9.6% quarter-over-quarter to $221M.
Based on Operose Advisors's 13F filing for Q2 2023, filed 9 Aug 2023.